Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Oral GLP-1s for obesity saw a recent setback when in April (April 2025), Pfizer announced that it was discontinuing development of danuglipron, an oral GLP-1 receptor agonist, which was being investigated for chronic weight management, due to potential liver toxicity
& Stenvinkel, P
The survey included 1,159 global healthcare professionals whose specialties ranged from primary care providers, physician assistants, nurse practitioners, cardiologists, endocrinologists, OBGYNs, and pediatric medicine
Here's what those phrases actually mean, broken down one by one: "Clinician Prescribed": Source - LIV Body's official lander
US$ 22.41
US$ 20.24
US$ 21.79
US$ 29.66
US$ 24.70
US$ 24.84
